7FQH
Crystal Structure of human Legumain in complex with (2S)-N-[(3S)-5-amino-5-oxopent-1-yn-3-yl]-1-[1-[4-(cyclopropylmethoxy)phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide
Summary for 7FQH
Entry DOI | 10.2210/pdb7fqh/pdb |
Group deposition | To be published (G_1002245) |
Descriptor | Legumain, N-[(3S)-5-amino-5-oxopent-1-en-3-yl]-1-{1-[4-(cyclopropylmethoxy)phenyl]cyclopropane-1-carbonyl}-L-prolinamide, 1,2-ETHANEDIOL, ... (5 entities in total) |
Functional Keywords | cysteine protease, allosteric inhibitor, asparaginyl endopeptidase, alzheimer's disease, hydrolase, hydrolase-inhibitor complex, hydrolase/inhibitor |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 3 |
Total formula weight | 154476.13 |
Authors | Ehler, A.,Benz, J.,Bartels, B.,Hewings-David, S.,Rudolph, M.G. (deposition date: 2022-10-05, release date: 2023-10-11, Last modification date: 2024-11-20) |
Primary citation | Bartels, B.,Kuhn, B.,Benz, J.,Rudolph, M.G. Crystal Structure of a human Legumain complex To be published, |
Experimental method | X-RAY DIFFRACTION (2.18 Å) |
Structure validation
Download full validation report